Revance therapeutics, inc. (rvnc) investors who lost money have opportunity to lead securities fraud lawsuit

Los angeles , jan. 31, 2025 /prnewswire/ -- the law offices of frank r. cruz announces that investors with losses related to revance therapeutics, inc. ("revance" or the "company") (nasdaq: rvnc) have opportunity to lead the securities fraud class action lawsuit.

RVNC Ratings Summary

RVNC Quant Ranking